Minuteful Kidney Healthy IO
A Voluntary Ex-Ante Transparency (VEAT) Notice
by NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- not specified
- Value
- £87K
- Sector
- INDUSTRIAL
- Published
- 17 Oct 2023
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
Hywel Ddda University Health Board
2 buyers
1 supplier
- Healthyio London
Description
Hywel Dda University Health Board seeks to award a contract to for the provision of Minuteful Kidney home albumin-to-creatinine ("ACR") testing. Minuteful Kidney is a home urine test for measuring ACR for use, in primary care, in patients at risk of chronic kidney disease (“CKD”).
Total Quantity or Scope
Minuteful Kidney is a home urine test for measuring albumin-to-creatinine ratio (“ACR”) for use, in primary care, in patients at risk of chronic kidney disease (“CKD”). The aim of the technology is to improve uptake of ACR testing in patients with conditions including diabetes and high blood pressure in order to promote early identification and treatment of CKD and reduce rates of end-stage renal disease (“ESRD”). The Health Board wish to pursue this new innovative technology within the North Ceredigion Cluster to boost the uptake of ACR testing and reduce the demand on primary and secondary care sites with staff time and resources saved. The solution provides an end to end service with the supplier assuming responsibility for onboarding patients and positively impacting cases to reduce acute kidney injury. The procurement is a pilot scheme as the technology is a new innovation and unique to the market with only one supplier in the niche marketspace. There are also no public procurement frameworks available to link the requirement to.
Award Detail
| 1 | Healthyio (London)
|
CPV Codes
- 71632000 - Technical testing services
Indicators
Legal Justification
Hywel Dda University Health Board seeks to direct award a contract to HEALTHY. IO (UK) LTD for the provision of Minuteful Kidney home albumin-to-creatinine ratio (“ACR”) testing for a two (2) year period from the 1st November 2023. The procurement is a pilot scheme as the technology is a new innovation and unique to the market with only one supplier in the niche marketspace. There are also no public procurement frameworks available to link the requirement to.
Other Information
NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at https://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=135298. (WA Ref:135298)
Reference
- FTS 030613-2023